Positive and negative modulation of nicotinic receptors

Advances in Protein Chemistry and Structural Biology

Volumn 80, Issue C, 2010, Pages 153-203

  Arias, Hugo R ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649884825     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381264-3.00005-9     Document Type: Chapter

References (184)

1. G. Akk, and J.H. Steinbach Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site J. Neurosci. 25 2005 1992 2001
2. E.X. Albuquerque, E.F. Pereira, M. Alkondon, and S.W. Rogers Mammalian nicotinic acetylcholine receptors: from structure to function Physiol. Rev. 89 2009 73 120
3. M. Alkondon, and E.X. Albuquerque Subtype-specific inhibition of nicotinic acetylcholine receptors by choline: a regulatory pathway J. Pharmacol. Exp. Ther. 318 2006 268 275
4. M. Alkondon, E.F. Pereira, W.S. Cortes, A. Maelicke, and E.X. Albuquerque Choline is a selective agonist of α7 nicotinic acetylcholine receptors in rat brain neurons Eur. J. Neurosci. 9 1997 2734 2742
5. 3 H]-A-998679: a novel positive allosteric modulator of α4β2 nAChRs Biochem. Pharmacol. 78 2009 903 904
6. D.J. Anderson, J. Malysz, J.H. Grønlien, R. El Kouhen, M. Hkerud, and C. Wetterstrand Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity α4β2 subunit combination Biochem. Pharmacol. 78 2009 844 851
7. T. Araud, S. Wonnacott, and D. Bertrand Associated proteins: the universal toolbox controlling ligand gated ion channel function Biochem. Pharmacol. 80 2010 160 169
8. H.R. Arias Ligand-gated ion channel receptor superfamilies H.R. Arias, Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies 2006 Research Signpost Kerala, India pp. 1 - 25
9. H.R. Arias Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? Int. J. Biochem. Cell Biol. 41 2009 2098 2108
10. H.R. Arias Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy V. Veissig, Liposomes, Methods in Molecular Biology Vol. 606 2010 The Humana Press Inc. USA 291 318
11. H.R. Arias Molecular interaction of bupropion with nicotine acetylcholine receptors J. Pediatr. Biochem. 1 2010 185 - 197
12. H.R. Arias, and P. Bhumireddy Anesthetics as chemical tools to study the structure and function of nicotinic acetylcholine receptors Curr. Protein Pept. Sci. 6 2005 451 472
13. H.R. Arias, and C.B. Bouzat Modulation of nicotinic acetylcholine receptors by noncompetitive antagonists H.R. Arias, Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies 2006 Research Signpost Kerala, India pp. 61 - 107
14. H.R. Arias, and C.B. Bouzat Activation and modulation of the nicotine receptor J. Pediatr. Biochem. 1 2010 53 - 73
15. H.R. Arias, P. Bhumireddy, and C. Bouzat Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors Int. J. Biochem. Cell Biol. 38 2006 1254 1276
16. H.R. Arias, F. Gumilar, A. Rosenberg, K.M. Targowska-Duda, D. Feuerbach, and K. Jozwiak Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states Biochemistry 48 2009 4506 4518
17. H.R. Arias, V. Richards, D. Ng, M.E. Ghafoori, V. Le, and S. Mousa Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis Int. J. Biochem. Cell Biol. 41 2009 1441 1451
18. H.R. Arias, D. Feuerbach, P. Bhumireddy, and M. Ortells Inhibitory mechanisms and binding site locations for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors Int. J. Biochem. Cell Biol. 42 2010 712 724
19. H.R. Arias, H. Gu, D. Feuerbach, and D.Q. Wei Different interaction between the agonist JN403 and the competitive antagonist methyllycaconitine with the human α7 nicotinic receptor Biochemistry 49 2010 4169 4180
20. H.R. Arias, A. Rosenberg, K.M. Targowska-Duda, D. Feuerbach, K. Jozwiak, and R. Moaddel Tricyclic antidepressants and mecamylamine bind to different sites in the human α4β2 nicotinic receptor ion channel Int. J. Biochem. Cell Biol. 42 2010 1007 1018
21. H.R. Arias, K.M. Targowska-Duda, C.J. Sullivan, D. Feuerbach, R. Maciejewski, and K. Jozwiak Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor Int. Neurochem. 56 2010 642 649
22. J.J. Arnaiz-Cot, J.C. Gonzlez, M. Sobrado, P. Baldelli, E. Carbone, and L. Ganda Allosteric modulation of α7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission Eur. J. Neurosci. 27 2008 1097 1110
23. J. Arredondo, A.I. Chernyavsky, D.L. Jolkovsky, R.J. Webber, and S.A. Grando SLURP-2: a novel cholinergic signaling peptide in human mucocutaneous epithelium Cell Physiol. 208 2006 238 245
24. A. Auerbach How to turn the reaction coordinate into time J. Gen. Physiol. 130 2007 543 546
25. I. Bacher, B. Wu, D.R. Shytle, and T.P. George Mecamylaminea nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders Expert Opin. Pharmacother. 10 2009 2709 2721
26. P.A. Bafna, P.G. Purohit, and A. Auerbach Gating at the mouth of the acetylcholine receptor channel: energetic consequences of mutations in the αM2-cap PLoS ONE 3 2008 e2515
27. S.C. Barron, J.T. McLaughlin, J.A. See, V.L. Richards, and R.L. Rosenberg An allosteric modulator of α7 nicotinic receptors, N-(5-chloro-2, 4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine Mol. Pharmacol. 76 2009 253 263
28. M. Bartos, J. Corradi, and C. Bouzat Structural basis of activation of Cys-loop receptors: the extracellular - transmembrane interface as a coupling region Mol. Neurobiol. 40 2009 236 252
29. M. Bartos, K.L. Price, S.C. Lummis, and C. Bouzat Glutamine 57 at the complementary binding site face is a key determinant of morantel selectivity for α7 nicotinic receptors J. Biol. Chem. 284 2009 21478 21487
30. O. Beckstein, and M.S. Sansom A hydrophobic gate in an ion channel: the closed state of the nicotinic acetylcholine receptor Phys. Biol. 3 2006 147 159
31. D. Bertrand, and M. Gopalakrishnan Allosteric modulation of α7 and α4β2 nicotinic acetylcholine receptors Biochem. Pharmacol. 74 2007 1155 1163
32. D. Bertrand, S. Bertrand, S. Cassar, E. Gubbins, J. Li, and M. Gopalakrishnan Positive allosteric modulation of the α7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2 - M3 segment Mol. Pharmacol. 74 2008 1407 1416
33. N. Bocquet, L. Prado de Carvalho, J. Cartaud, J. Neyton, C. Le Poupon, and A. Taly A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family Nature 445 2007 116 119
34. N. Bocquet, H. Nury, M. Baaden, C. Le Poupon, J. -P. Changeux, and M. Delarue X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation Nature 457 2009 111 114
35. C.E. Bond, M. Zimmermann, and S.A. Greenfield Upregulation of α7 nicotinic receptors by acetylcholinesterase C-terminal peptides PLoS ONE 4 2009 e4846
36. C. Bouzat, N. Bren, and S.M. Sine Structural basis of the different gating kinetics of fetal and adult nicotinic acetylcholine receptors Neuron 13 1994 1395 1402
37. C. Bouzat, F. Gumilar, M. Esandi, C. del, and S.M. Sine Subunit-selective contribution to channel gating of the M4 domain of the nicotinic receptor Biophys. J. 82 2002 1920 1929 (Pubitemid 34280807)
38. C. Bouzat, F. Gumilar, G. Spitzmaul, H.L. Wang, D. Rayes, and S.B. Hansen Coupling of agonist binding to channel gating in an ACh-binding protein linked to ion channel Nature 430 2004 896 900
39. G. Brannigan, J. Hnin, R. Law, R. Eckenhoff, and M.L. Klein Embedded cholesterol in the nicotinic acetylcholine receptor Proc. Natl Acad. Sci. USA 105 2007 14418 14423
40. K. Brejc, W.J. van Dijk, R.V. Klaassen, M. Schuurmans, J. van Der Oost, and A.B. Smit Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors Nature 411 2001 269 276
41. L.M. Broad, R. Zwart, K.H. Pearson, M. Lee, L. Wallace, and G.I. McPhie Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators J. Pharmacol. Exp. Ther. 318 2006 1108 1117
42. E. Bruneau, and M. Akaaboune The dynamics of the rapsyn scaffolding protein at individual acetylcholine receptor clusters J. Biol. Chem. 282 2007 9932 9940
43. J.M. Cederholm, P.R. Schofield, and T.M. Lewis Gating mechanisms in Cys-loop receptors Eur. Biophys. J. 39 2009 37 49
44. P.H. Celie, R.V. Klaassen, S.E. van Rossum-Fikkert, R. van Elk, P. van Nierop, and A.B. Smit Crystal structure of acetylcholine-binding protein from Bulinus truncatus reveals the conserved structural scaffold and sites of variation in nicotinic acetylcholine receptors J. Biol. Chem. 280 2005 26457 26466
45. Y. -C. Chang, W. Wu, J. -L. Zhang, and Y. Huang Allosteric activation mechanism of the cys-loop receptors Acta Pharmacol. Sin. 30 2009 663 672
46. J.-P. Changeux, and A. Taly Nicotinic receptors, allosteric proteins and medicine Trends Mol. Med. 14 2008 93 102
47. E. Charpantier, A. Wiesner, K.H. Huh, R. Ogier, J.C. Hoda, and G. Allaman α7 Neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases J. Neurosci. 25 2005 9836 9849
48. F. Chimienti, R.C. Hogg, L. Plantard, C. Lehmann, N. Brakch, and J. Fischer Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda Hum. Mol. Genet. 12 2003 3017 3024
49. C.H. Cho, W. Song, K. Leitzell, E. Teo, A.D. Meleth, and M.W. Quick Rapid upregulation of α7 nicotinic acetylcholine receptors by tyrosine dephosphorylation J. Neurosci. 25 2005 3712 3723
50. T. Collins, and N.S. Millar Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator Mol. Pharmacol. 78 2010 198 204
51. W.G. Conroy, Q.S. Liu, Q. Nai, J.F. Margiotta, and D.K. Berg Potentiation of α7-containing nicotinic acetylcholine receptors by select albumins Mol. Pharmacol. 63 2003 419 428
52. P.J. Corringer, M. Baaden, N. Bocquet, M. Delarue, V. Dufresne, and H. Nury Atomic structure and dynamics of pentameric ligand-gated ion channels: new insight from bacterial homologues J. Physiol. 588 Pt 4 2010 565 572
53. V. Costa, A. Nistri, A. Cavalli, and P. Carloni A structural model of agonist binding to the α3β4 neuronal nicotinic receptor Br. J. Pharmacol. 140 2003 921 931
54. M. Criado, J. Mulet, J.A. Bernal, S. Gerber, S. Sala, and F. Sala Mutations of a conserved lysine residue in the N-terminal domain of α7 nicotinic receptors affect gating and binding of nicotinic agonists Mol. Pharmacol. 68 2005 1669 1677
55. M.P. Cunha, D.G. Machado, L.E. Bettio, J.C. Capra, and A.L. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1913 1920
56. G.D. Cymes, and C. Grosman Pore-opening mechanism of the nicotinic acetylcholine receptor evinced by proton transfer Nat. Struct. Mol. Biol. 15 2008 389 396
57. G.D. Cymes, Y. Ni, and C. Grosman Probing ion-channel pores one proton at a time Nature 438 2005 975 980
58. 2+ conductance of nicotinic acetylcholine receptors by Lypd6 Eur. Neuropsychopharmacol. 19 2009 670 681
59. C.D. Dellisanti, Y. Yao, J.C. Stroud, Z.Z. Wang, and L. Chen Crystal structure of the extracellular domain of nAChR α1 bound to α-bungarotoxin at 1.94 resolution Nat. Neurosci. 10 2007 953 962
60. S. Di Angelantonio, V. Costa, P. Carloni, L. Messori, and A. Nistri A novel class of peptides with facilitating action on neuronal nicotinic receptors of rat chromaffin cells in vitro: functional and molecular dynamics studies Mol. Pharmacol. 61 2002 43 54
61. S. Di Angelantonio, R. Giniatullin, V. Costa, E. Sokolova, and A. Nistri Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells Br. J. Pharmacol. 139 2003 1061 1073
62. J. Dunlop, T. Lock, B. Jow, F. Sitzia, S. Grauer, and F. Jow Old and new pharmacology: positive allosteric modulation of the α7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine2B/C receptor antagonist SB-206553 (3, 5-dihydro-5-methyl-N-3-pyridinylbenzo[1, 2-b:4, 5-b′]dipyrrole-1(2H)-carboxamide) J. Pharmacol. Exp. Ther. 328 2009 766 776
63. M.O. Eriksson, E. Hagforsen, I.P. Lundin, and G. Michalsson Palmoplantar pustulosis: a clinical and immunohistological study Br. J. Dermatol. 138 1998 390 398
64. R. Faghih, S.M. Gopalakrishnan, J.H. Gronlien, J. Malysz, C.A. Briggs, and C. Wetterstrand Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H- pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the α7 nicotinic acetylcholine receptor J. Med. Chem. 52 2009 3377 3384
65. B. Favre, L. Plantard, L. Aeschbach, N. Brakch, S. Christen-Zaech, and P.A. de Viragh SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda J. Invest. Dermatol. 127 2007 301 308
66. N.B. Fedorov, L.C. Benson, J. Graef, and P.M. Lippiello Differential pharmacologies of mecamylamine enantiomers: positive allosteric modulation of noncompetitive inhibition J. Pharmacol. Exp. Ther. 328 2009 525 532
67. P.A. Ferchmin, R.J. Lukas, R.M. Hann, J.D. Fryer, J.B. Eaton, and O.R. Pagn Tobacco cembranoids block behavioral sensitization to nicotine and inhibit neuronal acetylcholine receptor function J. Neurosci. Res. 64 2001 18 25
68. P.A. Ferchmin, J. Hao, D. Perez, M. Penzo, H.M. Maldonado, and M.T. Gonzalez Tobacco cembranoids protect the function of acute hippocampal slices against NMDA by a mechanism mediated by α4β2 nicotinic receptors J. Neurosci. Res. 82 2005 631 641
69. P.A. Ferchmin, O.R. Pagn, H. Ulrich, A.C. Szeto, R.M. Hann, and V.A. Eterovi Actions of octocoral and tobacco cembranoids on nicotinic receptors Toxicon 54 2009 1174 1182
70. J. Garca-Colunga, M. Gonzlez-Herrera, and R. Miledi Modulation of α2β4 neuronal nicotinic acetylcholine receptors by zinc NeuroReport 12 2001 147 150 (Pubitemid 32099045)
71. J. Garca-Colunga, E. Vzquez-Gmez, and R. Miledi Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors Pharmacogenomics J. 4 2004 388 393
72. T.P. George, K.A. Sacco, J.C. Vessicchio, A.H. Weinberger, and R.D. Shytle Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study J. Clin. Psychopharmacol. 28 2008 340 344
73. R. Giniatullin, A. Nistri, and J.L. Yakel Desensitization of nicotinic ACh receptors: shaping cholinergic signaling Trends Neurosci. 28 2005 371 378
74. T.F. Gonzlez-Cestari, B.J. Henderson, R.E. Pavlovicz, S.B. McKay, R.A. El-Hajj, and A.B. Pulipaka Effect of novel negative allosteric modulators of nicotinic receptors on cells expressing native and recombinant nicotinic receptors: implications for drug discovery J. Pharmacol. Exp. Ther. 328 2009 504 515
75. S.R. Grady, O. Salminen, J.M. McIntosh, M.J. Marks, and A.C. Collins Mouse striatal dopamine nerve terminals express α4α5β2 and two stoichiometric forms of α4β2*-nicotinic acetylcholine receptors J. Mol. Neurosci. 40 2010 91 95
76. S.A. Grando Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors J. Pharmacol. Sci. 106 2008 174 179
77. S.A. Greenfield, T. Day, E.O. Mann, and I. Bermudez A novel peptide modulates α7 nicotinic receptor responses: implications for a possible trophic - toxic mechanism within the brain J. Neurochem. 90 2004 325 331
78. J.H. Grønlien, M. Hkerud, H. Ween, K. Thorin-Hagene, C.A. Briggs, and M. Gopalakrishnan Distinct profiles of α7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes Mol. Pharmacol. 72 2007 715 724
79. T. Grutter, L. Prado de Carvalho, N. Le Novre, P. -J. Corringer, S. Edelstein, and J. -P. Changeux An H-bond between two residues from different loops of the acetylcholine binding site contributes to the activation mechanism of nicotinic receptors EMBO J. 22 2003 1990 2003
80. F. Gumilar, H.R. Arias, G. Spitzmaul, and C. Bouzat Molecular mechanism of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants Neuropharmacology 45 2003 964 976
81. E. Hagforsen, M. Edvinsson, K. Nordlind, and G. Michalsson Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis Br. J. Dermatol. 146 2002 383 391
82. S.B. Hansen, and P. Taylor Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-α-subunit interfaces of heteromeric neuronal nicotinic receptors J. Mol. Biol. 369 2007 895 901
83. S.B. Hansen, G. Sulzenbacher, T. Huxford, P. Marchot, P. Taylor, and Y. Bourne Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations EMBO J. 24 2005 3635 3646
84. A receptor J. Neurosci. 28 2008 3490 3499
85. K. Hashimoto, K. Koike, E. Shimizu, and M. Iyo α7 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia Curr. Med. Chem.CNS Agents 5 2005 171 184
86. B.J. Henderson, R.E. Pavlovicz, J.D. Allen, T.F. Gonzlez-Cestari, C.M. Orac, and A.B. Bonnell Negative allosteric modulators that target human α4β2 neuronal nicotinic receptors J. Pharmacol. Exp. Ther. 334 2010 761 774
87. R.E. Hibbs, Z. Radic, P. Taylor, and D.A. Johnson Influence of agonists and antagonists on the segmental motion of residues near the agonist binding pocket of the acetylcholine-binding protein J. Biol. Chem. 281 2006 39708 39718
88. R.J. Hilf, and R. Dutzler X-ray structure of a prokaryotic pentameric ligand-gated ion channel Nature 452 2008 375 379
89. R.J. Hilf, and R. Dutzler Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel Nature 457 2009 115 118
90. M. Holford, S. Auer, M. Laqua, and I. Ibaez-Tallon Manipulating neuronal circuits with endogenous and recombinant cell-surface tethered modulators Front. Mol. Neurosci. 2 2009 1 10
91. M. Hruska, J. Keefe, D. Wert, A.B. Tekinay, J.J. Hulce, and I. Ibaez-Tallon Prostate stem cell antigen is an endogenous lynx1-like prototoxin that antagonizes α7-containing nicotinic receptors and prevents programmed cell death of parasympathetic neurons J. Neurosci. 29 2009 14847 14854
92. B. Hsiao, D. Dweck, and C.W. Luetje Subunit-dependent modulation of neuronal nicotinic receptors by zinc J. Neurosci. 21 2001 1848 1856
93. B. Hsiao, K.B. Mihalak, S.E. Repicky, D. Everhart, A.H. Mederos, and A. Malhotra Determinants of zinc potentiation on the α4 subunit of neuronal nicotinic receptors Mol. Pharmacol. 69 2006 27 36
94. B. Hsiao, K.B. Mihalak, K.L. Magleby, and C.W. Luetje Zinc potentiates neuronal nicotinic receptors by increasing burst duration J. Neurophysiol. 99 2008 999 1007
95. M. Hu, M. Gopalakrishnan, and J. Li Positive allosteric modulation of α7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons Br. J. Pharmacol. 158 2009 1857 1864
96. R.S. Hurst, M. Hajs, M. Raggenbass, T.M. Wall, N.R. Higdon, and J.A. Lawson A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization J. Neurosci. 25 2005 4396 4405
97. I. Ibaez-Tallon, J.M. Miwa, H. -L. Wang, N.C. Adams, G.W. Crabtree, and S.M. Sine Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1 Neuron 33 2002 893 903
98. B. Iorga, D. Herlem, E. Barr, and C. Guillou Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach J. Mol. Model. 12 2006 366 372
99. I. Ivanov, X. Cheng, S.M. Sine, and J.A. McCammon Barriers to ion translocation in cationic and anionic receptors from the Cys-loop family J. Am. Chem. Soc. 129 2007 8217 8224
100. A. Jha, D.J. Cadugan, P. Purohit, and A. Auerbach Acetylcholine receptor gating at extracellular transmembrane domain interface: the cys-loop and M2 - M3 linker J. Gen. Physiol. 130 2007 547 558 (Pubitemid 350179573)
101. O.T. Jones, and M.G. McNamee Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor Biochemistry 27 1988 2364 2374
102. J.-S. Kim, A. Padnya, M. Weltzin, B.W. Edmonds, M.K. Schulte, and R.A. Glennon Synthesis of desformylflustrabromine and its evaluation as an α4β2 and α7 nACh receptor modulator Bioorg. Med. Chem. Lett. 17 2007 4855 4860
103. R.M. Krause, B. Buisson, S. Bertrand, P. -J. Corringer, J. -L. Galzi, and J. -P. Changeux Ivermectin: a positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor Mol. Pharmacol. 53 1998 283 294 (Pubitemid 28099739)
104. R.J. Law, R.H. Henchman, and J.A. McCammon A gating mechanism proposed from a simulation of a human α7 nicotinic acetylcholine receptor Proc. Natl Acad. Sci. USA 102 2005 6813 6818
105. N. Le Novre, P.J. Corringer, and J. -P. Changeux The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences J. Neurobiol. 53 2002 447 456
106. W.Y. Lee, and S.M. Sine Principal pathway coupling agonist binding to channel gating in nicotinic receptors Nature 438 2005 243 247
107. W.Y. Lee, C.R. Free, and S.M. Sine Nicotinic receptor interloop proline anchors β1 - β2 and Cys loops in coupling agonist binding to channel gating J. Gen. Physiol. 132 2008 265 728
108. W.Y. Lee, C.R. Free, and S.M. Sine Binding to gating transduction in nicotinic receptors: Cys-loop energetically couples to pre-M1 and M2 - M3 regions J. Neurosci. 29 2009 3189 3199
109. 7 nicotinic acetylcholine receptor Biochem. Pharmacol. 78 2009 912
110. E.D. Levin, and D.P. Caldwell Low doses of mecamylamine improve learning on the radial-arm maze repeated acquisition task Neurobiol. Learn. Mem. 86 2006 117 122
111. E.D. Levin, and B.B. Simon Nicotinic acetylcholine involvement in cognitive function in animals Psychopharmacology (Berl.) 138 1998 217 230
112. A.P. Lightfoot, J.N.C. Kew, and J. Skidmore α7 Nicotinic acetylcholine receptor agonists and positive allosteric modulators Prog. Med. Chem. 46 2008 131 171
113. P.M. Lippiello, J.S. Beaver, G.J. Gatto, J.W. James, K.G. Jordan, and V.M. Traina TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity CNS Neurosci. Ther. 14 2008 266 277
114. C. Lopes, E.F. Pereira, H.Q. Wu, P. Purushottamachar, V. Njar, and R. Schwarcz Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at α7* nicotinic receptors J. Pharmacol. Exp. Ther. 322 2007 48 58
115. G.Y. Lpez-Hernndez, J.S. Thinschmidt, P. Morain, C. Trocme-Thibierge, W.R. Kem, and F. Soti Positive modulation of α7 nAChR responses in rat hippocampal interneurons to full agonists and the α7-selective partial agonists, 4OH-GTS-21 and S 24795 Neuropharmacology 56 2009 821 830
116. E. Luttmann, J. Ludwig, A. Hffle-Maas, M. Samochocki, A. Maelicke, and G. Fels Structural model for the binding sites of allosterically potentiating ligands on nicotinic acetylcholine receptors ChemMedChem 4 2009 1874 1882
117. L.K. Lyford, A.D. Sproul, D. Eddins, J.T. McLaughlin, and R.L. Rosenberg Agonist-induced conformational changes in the extracellular domain of α7 nicotinic acetylcholine receptors Mol. Pharmacol. 64 2003 650 658
118. A. Maelicke, A. Schrattenholz, M. Samochocki, M. Radina, and E.X. Albuquerque Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease Behav. Brain Res. 113 2000 199 206 (Pubitemid 30645557)
119. A. Maelicke, A. Hoeffle-Maas, J. Ludwig, A. Maus, M. Samochocki, and U. Jordis Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy J. Mol. Neurosci. 40 2010 135 137
120. J. Malysz, T. Dyhring, P.K. Ahring, G.M. Olsen, D. Peters, and J.H. Grønlien In vitro pharmacological profile of a novel α4β2 positive allosteric modulator NS9283 (A-969933) Biochem. Pharmacol. 78 2009 919 920
121. J. Malysz, J.H. Grønlien, D.J. Anderson, M. Hkerud, K. Thorin-Hagene, and H. Ween In vitro pharmacological characterization of a novel allosteric modulator of α7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile J. Pharmacol. Exp. Ther. 330 2009 257 267
122. R. Mastrangeli, S. Donini, C.A. Kelton, C. He, A. Bressan, and F. Milazzo ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda Eur. J. Dermatol. 13 2003 560 570
123. 2 nicotinic receptor expression and functional toxicity in paraoxon-treated rats Environ. Toxicol. Pharmacol. 26 2008 247 254
124. J. Militante, B.W. Ma, G. Akk, and J.H. Steinbach Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies Mol. Pharmacol. 74 2008 764 776
125. A. Mitra, T.D. Bailey, and A. Auerbach Structural dynamics of the M4 transmembrane segment during acetylcholine receptor gating Structure 12 2004 1909 1918 (Pubitemid 39298974)
126. J.M. Miwa, I. Ibanez-Tallon, G.W. Crabtree, R. Snchez, A. Sali, and L.W. Role Lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS Neuron 23 1999 105 114
127. J.M. Miwa, T.R. Stevens, S.L. King, B.J. Caldarone, I. Ibanez-Tallon, and C. Xiao The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo Neuron 51 2006 587 600
128. A. Miyazawa, Y. Fujiyoshi, and N. Unwin Structure and gating mechanism of the acetylcholine receptor pore Nature 423 2003 949 955
129. Y. Moriwaki, K. Yoshikawa, H. Fukuda, Y.X. Fujii, H. Misawa, and K. Kawashima Immune system expression of SLURP-1 and SLURP-2, two endogenous nicotinic acetylcholine receptor ligands Life Sci. 80 2007 2365 2368
130. Y. Moriwaki, Y. Watanabe, T. Shinagawa, M. Kai, M. Miyazawa, and T. Okuda Primary sensory neuronal expression of SLURP-1, an endogenous nicotinic acetylcholine receptor ligand Neurosci. Res. 64 2009 403 412
131. M. Moroni, R. Zwart, E. Sher, B.K. Cassels, and I. Bermudez α4β2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine Mol. Pharmacol. 70 2006 755 768
132. 2+ potentiation J. Neurosci. 28 2008 6884 6894
133. S.A. Mousa, and H.R. Arias Angiogenesis modulation by nicotine and nicotinic ligands J. Pediatr. Biochem. 1 2010, 91 - 104
134. N. Mukhtasimova, C. Free, and S.M. Sine Initial coupling of binding to gating mediated by conserved residues in the muscle nicotinic receptor J. Gen. Physiol. 126 2005 23 39
135. N. Mukhtasimova, W.Y. Lee, H.L. Wang, and S.M. Sine Detection and trapping of intermediate states priming nicotinic receptor channel opening Nature 459 2009 451 454
136. A receptor modulators Proc. Natl Acad. Sci. USA 104 2007 8059 8064
137. H. Nury, N. Bocquet, C. Le Poupon, B. Raynal, A. Haouz, and P. -J. Corringer Crystal structure of the extracellular domain of a bacterial ligand-gated ion channel J. Mol. Biol. 395 2010 1114 1127
138. M.O. Ortells, and H.R. Arias Neuronal networks of nicotine addiction Int. J. Biochem. Cell Biol. 2010 42, 1931 - 1935
139. Y. Paas, G. Gibor, R. Grailhe, N. Savatier-Duclert, V. Dufresne, and M. Sunesen Pore conformations and gating mechanism of a Cys-loop receptor Proc. Natl Acad. Sci. USA 102 2005 15877 15882
140. R.L. Papke, P.R. Sanberg, and R.D. Shytle Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes J. Pharmacol. Exp. Ther. 297 2001 646 656
141. K. Paradiso, J. Zhang, and J.H. Steinbach The C terminus of the human nicotinic α4β2 receptor forms a binding site required for potentiation by an estrogenic steroid J. Neurosci. 21 2001 6561 6568
142. A. Pettersson, S. Nordlander, G. Nylund, A. Khorram-Manesh, S. Nordgren, and D.S. Delbro Expression of the endogenous, nicotinic acetylcholine receptor ligand, SLURP-1, in human colon cancer Auton. Autacoid Pharmacol. 28 2008 109 116
143. P.V. Plazas, M.J. De Rosa, M.E. Gomez-Casati, M. Verbitsky, N. Weisstaub, and E. Katz Key roles of hydrophobic rings of TM2 in gating of the α9α10 nicotinic cholinergic receptor Br. J. Pharmacol. 145 2005 963 974
144. R.L. Rabenstein, B.J. Caldarone, and M.R. Picciotto The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not β2- or α7-nicotinic acetylcholine receptor subunit knockout mice Psychopharmacology (Berl.) 189 2006 395 401
145. 3 A receptors Mol. Pharmacol. 68 2005 1475 1483
146. D. Rayes, M.J. De Rosa, S.M. Sine, and C. Bouzat Number and locations of agonist binding sites required to activate homomeric Cys-loop receptors J. Neurosci. 29 2009 6022 6032
147. M.S. Reid, B. Angrist, S.A. Baker, S. O'leary, J. Stone, and M. Schwartz A placebo controlled, double-blind study of mecamylamine treatment for cocaine dependence in patients enrolled in an opiate replacement program Subst. Abus. 26 2005 5 14
148. F. Sala, J. Mulet, K.P. Reddy, J.A. Bernal, P. Wikman, and L.M. Valor Potentiation of human α4β2 neuronal nicotinic receptors by a Flustra foliacea metabolite Neurosci. Lett. 373 2005 144 149
149. M. Samochocki, A. Hoffle, A. Fehrenbacher, R. Jostock, J. Ludwig, and C. Christner Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors J. Pharmacol. Exp. Ther. 305 2003 1024 1036
150. D.B. Sattelle, S.D. Buckingham, M. Akamatsu, K. Matsuda, I.S. Pienaar, and A.K. Jones Comparative pharmacology and computational modelling yield insights into allosteric modulation of human α7 nicotinic acetylcholine receptors Biochem. Pharmacol. 78 2009 836 843
151. A. Schrattenholz, J. Godovac-Zimmermann, H.J. Schfer, E.X. Albuquerque, and A. Maelicke Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine Eur. J. Biochem. 216 1993 671 677
152. H.S. Sekhon, P. Song, Y. Jia, J. Lindstrom, and E.R. Spindel Expression of lynx1 in developing lung and its modulation by prenatal nicotine exposure Cell Tissue Res. 320 2005 287 297
153. S. Seo, J.T. Henry, A.H. Lewis, N. Wang, and M.M. Levandoski The positive allosteric modulator morantel binds at noncanonical subunit interfaces of
154. R.D. Shytle, A.A. Silver, R.J. Lukas, M.B. Newman, D.V. Sheehan, and P.R. Sanberg Nicotinic receptors as targets for antidepressants Mol. Psychiatry 7 2002 525 535
155. R.D. Shytle, A.A. Silver, K.H. Sheehan, D.V. Sheehan, and P.R. Sanberg Neuronal nicotinic receptor inhibition for treating mood disorders: preliminary controlled evidence with mecamylamine Depress. Anxiety 16 2002 89 92
156. S.M. Sine, and A.G. Engel Recent advances in Cys-loop receptor structure and function Nature 440 2006 448 455
157. M. Siwek, D. Dudek, I.A. Paul, M. Sowa-Kuma, A. Zieba, and P. Popik Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study J. Affect. Disord. 118 2009 187 195
158. C.J.G.M. Smulders, R. Zwart, I. Bermudez, R.G.D.M. van Kleef, P.J. Groot-Kormelink, and H.P.M. Vijverberg Cholinergic drugs potentiate human nicotinic α4β2 acetylcholine receptors by a competitive mechanism Eur. J. Pharmacol. 509 2005 97 108
159. 3 A receptor kinetics: interpretation within an allosteric kinetic model J. Neurosci. 27 2007 13151 13160
160. P. Song, H.S. Sekhon, X.W. Fu, M. Maier, Y. Jia, and J. Duan Activated cholinergic signaling provides a target in squamous cell lung carcinoma Cancer Res. 68 2008 4693 4700
161. G. Spitzmaul, J.P. Dilger, and C. Bouzat The noncompetitive inhibitor quinacrine modifies the desensitization kinetics of muscle acetylcholine receptors Mol. Pharmacol. 60 2001 235 243
162. G. Spitzmaul, F. Gumilar, J.P. Dilger, and C. Bouzat The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms Br. J. Pharmacol. 157 2009 804 817
163. A. Storch, A. Schrattenholz, J.C. Cooper, E.M. Abdel Ghani, O. Gutbrod, and K.H. Weber Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells Eur. J. Pharmacol. 290 1995 207 219
164. B. Szewczyk, E. Poleszak, M. Sowa-Kuma, M. Siwek, D. Dudek, and B. Ryszewska-Pokraniewicz Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action Pharmacol. Rep. 60 2008 588 599
165. 3 human acetylcholine receptors Mol. Pharmacol. 71 2007 769 776
166. A. Tasneem, L.M. Iyer, E. Jakobsson, and L. Aravind Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels Genome Biol. 6 2005 R4
167. A.B. Tekinay, Y. Nong, J.M. Miwa, I. Lieberam, I. Ibaez-Tallon, and P. Greengard A role for LYNX2 in anxiety-related behavior Proc. Natl. Acad. Sci. USA 106 2009 4477 4482
168. A.V. Terry Jr., J.J. Buccafusco, and M.A. Prendergast Dose-specific improvements in memory-related task performance by rats and aged monkeys administered the nicotinic-cholinergic antagonist mecamylamine Drug Dev. Res. 47 1999 127 136
169. D.B. Timmermann, J.H. Grønlien, K.L. Kohlhaas, E.Ø. Nielsen, E. Dam, and T.D. Jørgensen An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo J. Pharmacol. Exp. Ther. 323 2007 294 307
170. H. Ulrich, G. Akk, A.A. Nery, C.A. Trujillo, A.D. Rodriguez, and V.A. Eterovi Mode of cembranoid action on embryonic muscle acetylcholine receptor J. Neurosci. Res. 86 2008 93 107
171. N. Unwin Refined structure of the nicotinic acetylcholine receptor at 4 resolution J. Mol. Biol. 346 2005 967 989
172. E. Vzquez-Gmez, and J. Garca-Colunga Neuronal nicotinic acetylcholine receptors are modulated by zinc Neuropharmacology 56 2009 1035 1040
173. K. Vogt, J. Mellor, G. Tong, and R. Nicoll The actions of synaptically released zinc in hippocampal mossy fiber synapses Neuron 26 2000 187 196
174. J.C. Webster, M.M. Francis, J.K. Porter, G. Robinson, C. Stokes, and B. Horenstein Antagonist activities of mecamylamine and nicotine show reciprocal dependence on beta subunit sequence in the second transmembrane domain Br. J. Pharmacol. 127 1999 1337 1348
175. M.M. Weltzin, and M.K. Schulte Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with α4β2 neuronal nicotinic acetylcholine receptor orthosteric ligands J. Pharmacol. Exp. Ther. 334 2010 917 926
176. X. Xiu, A.P. Hanek, J. Wang, H.A. Lester, and D.A. Dougherty A unified view of the role of electrostatic interactions in modulating the gating of Cys loop receptors J. Biol. Chem. 280 2005 41655 41666
177. R.F. Yoshimura, D.J. Hogenkamp, W.Y. Li, M.B. Tran, J.D. Belluzzi, and E.R. Whittemore Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats J. Pharmacol. Exp. Ther. 323 2007 907 915
178. G.T. Young, R. Zwart, A.S. Walker, E. Sher, and N.S. Millar Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site Proc. Natl. Acad. Sci. USA 105 2008 14686 14691
179. V. Zbarsky, J. Thomas, and S. Greenfield Bioactivity of a peptide derived from acetylcholinesterase: involvement of an ivermectin-sensitive site on the α7 nicotinic receptor Neurobiol. Dis. 16 2004 283 289
180. C. Zheng, M.Y. Wang, Q. Liu, M. Wakui, P. Whiteaker, and R.J. Lukas U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line J. Neurochem. 108 2009 1526 1538
181. R. Zwart, and H.P.M. Vijverberg Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects Mol. Pharmacol. 52 1997 886 895
182. R. Zwart, and H.P.M. Vijverberg Potentiation and inhibition of neuronal α4β4 nicotinic acetylcholine receptors by choline Eur. J. Pharmacol. 393 2000 209 214
183. R. Zwart, G. De Filippi, L.M. Broad, G.I. McPhie, K.H. Pearson, and T. Baldwinson 5-Hydroxyindole potentiates human α7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices Neuropharmacology 43 2002 374 384
184. R. Zwart, L.M. Broad, Q. Xi, M. Lee, M. Moroni, and I. Bermudez 5-I A-85380 and TC-2559 differentially activate heterologously expressed α4β2 nicotinic receptors Eur. J. Pharmacol. 539 2006 10 17